1-2 of 2
Zhanfang Guo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C200: Effects of PI3K/Akt pathway inhibition on global proteome levels and phosphorylation signaling in patient-derived xenograft models of triple negative breast cancer

Free
Filip O. Mundt, Cynthia Ma, Philipp Mertins, Zhanfang Guo, Matthew Meyer, Jana Qiao, DR Mani, Karl Clauser, Shunqiang Li, Kuan Huang, Jason Held, Sherri Davies, Kelly Ruggles, Li Ding, Michael Gillette, David Fenyo, Reid Townsend, Matthew Ellis, Steven A. Carr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C200.
https://doi.org/10.1158/1535-7163.TARG-15-C200
Published: 01 December 2015
View articletitled, Abstract C200: Effects of PI3K/Akt pathway inhibition on global proteome levels and phosphorylation signaling in patient-derived xenograft models of triple negative breast cancer
Journal Articles

Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models

Free
Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, Cynthia X. Ma
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1665–1675.
https://doi.org/10.1158/1535-7163.MCT-13-0159
Published: 08 August 2013
View articletitled, Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models
Open the PDF for Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models in another window
Includes: Supplementary data